Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Clinical Chemistry|March 10, 2001
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart diseaseN Rifai, P M Ridker
Vascular Medicine (London, England)|January 16, 2002
Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosisM A Albert, N Rifai, P M Ridker
Circulation|February 7, 2001
Soluble P-selectin and the risk of future cardiovascular eventsP M Ridker, J E Buring, N Rifai
Circulation|March 10, 2001
Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemiaP M Ridker, N Rifai, S P Lowenthal
Clinical Chemistry|December 10, 1999
Clinical efficacy of an automated high-sensitivity C-reactive protein assayN Rifai, R P Tracy, P M Ridker
JAMA|May 23, 2001
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial diseaseP M Ridker, M J Stampfer, N Rifai
Journal of the American College of Cardiology|July 18, 2000
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screeningR F Redberg, N Rifai, L Gee, et al.
JAMA|July 4, 2001
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort studyM A Albert, E Danielson, N Rifai, et al.
The New England Journal of Medicine|March 25, 2000
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenP M Ridker, C H Hennekens, J E Buring, et al.
Hypertension (Dallas, Tex. : 1979)|September 22, 2001
Blood pressure and inflammation in apparently healthy menC U Chae, R T Lee, N Rifai, et al.
Pageof 29